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dilica under mild conditions. In contrast to CSP with immobilized vancomycin, which is a close structural analogue of eremomycin, the prepared
SP reveals high enantioselectivity for separation of amino acids enantiomers. It was demonstrated by the example of ristocetin A CSP that method
f the immobilization of macrocyclic glycopeptide antibiotics affects remarkably the resulting enantioselectivity.
2006 Elsevier B.V. All rights reserved.
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. Introduction
In recent years, the chiral stationary phases (CSPs) with cova-
ently bonded macrocyclic glycopeptide antibiotics are found as
ne of the most versatile and selective chiral selectors for sep-
ration of different classes of chiral compounds [1–10]. This is
ostly due to presence of various chiral recognition sites pro-
iding multiple stereoselective interactions with analytes. The
nantioselectivity of silica-based CSP with attached macrocyclic
lycopeptide antibiotics depends mainly on their chemical struc-
ure. So teicoplanin [2,11] and ristocetin A [3,8,11] containing
SPs reveals a high selectivity for separation of amino acid
nantiomers, while vancomycin bonded CSP Chirobiotic V has
o enantioselectivity to these substances [1,11].
Another possibility to get new enantioselectivity of CSP is a
hemical modification of macrocyclic glycopeptide antibiotics.
erthod et al. [5] used teicoplanin aglycone for preparation of
SP with enhanced enantioselectivity for amino acids. Ghas-
empour et al. [12] prepared two crystalline degradation prod-
ucts (CDPs) of vancomycin by alkaline hydrolysis. The attach-
ment of CDP to aminopropylsilica resulted in CSPs having high
enantioselectivity in separation of aromatic amino acids that was
not noted for Chirobiotic V. The immobilization chemistry of
antibiotics is also of great importance as shown by D’Acquarica
[13], who synthesized and compared eleven teicoplanin contain-
ing CSPs.
The present investigation deals with preparation of new
CSP with macrocyclic glycopeptide antibiotic eremomycin. The
enantioselectivity of resulting CSP for separation of amino acid
enantiomers was evaluated.
2. Experimental
2.1. Synthesis of CSPs
Eremomycin and ristocetin A were supplied by Institute
of New Antibiotics of Russian Academy of Medical Sciences
[14,15]. The purity of antibiotics was controlled by RP HPLC
and was about 95%. Vancomycin hydrochloride was purchased
from Lilly Pharma Fertigung (Germany).∗ Corresponding author. Tel.: +7 95 9394416; fax: +7 95 9394675.
E-mail address: PavelN@analyt.chem.msu.ru (P.N. Nesterenko).
The initial solution was prepared by dissolving 1 g of ere-
momycin sulphate in 15 ml of distilled water. The pH of solutions
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was adjusted to 8.6 with 1 M KOH. The solution was mixed
with 3 g of Diaspher-110-Epoxy (5m, 300 m2/g, pore diameter
11 nm, carbon content 5.2% C) obtained from JSC BioChem-
Mack S&T (Moscow, Russia). The prepared suspension was
stirred at 40 ◦C within 14 h, whereupon sorbent was filtered and
washed by water, methanol and acetone and dried at 50 ◦C for
4 h. The similar procedure was used for attachment of ristocetin
A and vancomycin, when 1 g vancomycin or 1.2 g ristocetin
A reacted with 5 g Diaspher-110-Epoxy with addition of 4 ml
ethanol to solutions of antibiotics for better solubility. The data
of element analysis showed 9.5% C, 1.5% H, 3.3% N; 13.1% C,
1.9% H, 1.6% N; 8.7% C, 1.3% H and 1.8% N for eremomycin,
ristocetin A and vancomycin CSPs, correspondingly. It was cor-
responded to surface concentration 0.17–0.28mol of bonded
antibiotics per m2.
2.2. Chromatography
The prepared CSPs were slurry packed into 250 mm × 4 mm
i.d. stainless steel columns at 600 bars. The pure methanol
was used as a slurry solvent and 1 M ammonium acetate water
solution was used for washing of packed column. The column
efficiencies calculated from chromatographic peaks of xylene
eluted in isooctane–isopropanol mixture (99:1) were 53,850 and
24,427 theoretical plates per meter for vancomycin CSP and ris-
tocetin A CSP columns, correspondingly. The chromatographic
system consisted of K-1001 gradient pump, spectrophotomet-
ric detector K-2501, injection valve equipped with 20l sample
loop (all from Knauer GmbH, Berlin, Germany). All solvents
were of chromatographic grade unless otherwise stated. All
solutions were prepared using deionized water from Milli-Q
(Millipore, Bedford, MA, USA). Amino acid standards were
purchased from Sigma-Aldrich.
The chemical purity and concentration of macrocyclic gly-
copeptide antibiotics in reaction mixtures was controlled by RP
HPLC on a 150 mm × 4.0 mm i.d. Diaspher-110-C18 column
(JSC BioChemMack S&T) with mobile phase, A: 0.05% trifluo-
roacetic acid; B: acetonitrile–0.05% trifluoroacetic acid (42:58);
linear gradient from 10% B to 60% B in 20 min; flow rate
0.8 ml/min, T = 25 ◦C, UV detection at 220 or 280 nm. To eval-
uate the quality of chromatographic separations of enantiomers
of amino acids, the resolution RS = 1.177(tR,2 − tR,1)/(w0.5b,1 +
w0.5b,2), and the separation factor α=k2/k1 are used. The columns
dead time (t0) was estimated by injection of solution of toluene
in methanol using 100% methanol as eluent.
3. Results and discussion
The chemical structure of eremomycin includes 22 chiral


























hromatographic data for resolution of racemic amino acids on eremomycin
SP
mino acid Mobile phase kL α = kD/kL RS
l-Alanine A 0.26 2.37 2.94
B 0.21 2.86 4.95
l--Aminobutyric acid A 0.23 3.39 4.80
l-Valine A 0.20 3.35 4.09
B 0.21 3.29 5.02
l-Norvaline A 0.26 2.65 3.76
B 0.22 3.32 5.75
l-Leucine A 0.22 2.54 3.64
l-Norleucine B 0.26 2.00 3.47
l-Serine B 0.18 1.50 1.55
l-Threonine B 0.14 1.35 0.84
l-Methionine A 0.26 2.23 4.19
B 0.28 2.21 4.60
l-Citrulline B 0.38 1.58 2.65
l-Proline A 0.47 7.94 7.73
l-Pipecolinic acid A 0.55 11.0 6.46
l-Phenylglycine A 0.33 3.09 6.42
l-Phenylalanine B 0.55 4.33 6.64
l-Tyrosine A 0.39 5.05 9.91
l-3,4-Dihydroxyphenylalanine A 0.72 4.28 10.03
l-m-Fluorotyrosine B 0.84 3.11 6.87l-Tryptophan A 1.12 1.81 4.30
B 2.47 1.73 4.86
l-(2-Thienyl)-Ala B 0.93 2.75 9.50
obile phases consisted of: A = methanol/water (50:50, v/v) and
= methanol/0.1 M NaH2PO4 (20:80, v/v).
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boxylic group, 9 hydroxyl groups, 7 amido groups and 3 amino
groups (Fig. 1). Eremomycin differs from vancomycin in the
structure of trinucleus amino acid fragment. In this fragment,
eremomycin has one chloro substituted aromatic ring, while van-
comycin has two (Fig. 1). Eremomycin is a single molecule in
vancomycin-related group of antibiotics having atom of chlo-
rine in the N-terminal part of the aglycone [16]. Carbohy-
drate part of eremomycin molecule contains residues of glu-
cose and eremosamine or 2,3,6-trideoxy-3-amino-3-C-methyl-
arabinohexopiranose. The difference between eremosamine and
vancosamine, which is a part of vancomycin, is in configuration
of C-4 (lixohexopiranose) or 4-epi-vancosamine. Eremomycin
has also two amino sugar residues [14] but not one as van-
comycin.
The immobilization of eremomycin on epoxy-activated silica
takes place under mild conditions from water solution and pro-
vides substantial bonding density of 50mol/g or 0.17mol/m2
that is comparable with 0.20mol/m2 published for vancomycin
Table 2
The effect of the type of immobilization on enantioselectivity of prepared CSPs
(eluent: methanol–water, 50:50, v/v)
Amino acid Ristocetin Aa Ristocetin Ab
α RS α RS
3,4-Dihydroxyphenylalanine 2.50 5.11 1.33 1.4
Tyrosine 2.66 4.50 1.30 1.52
Tryptophan 2.03 4.65 1.23 1.55
Methionine 2.13 4.22 1.15 1.52
-Aminobutyric acid 1.30 1.42 1.26 1.56
Leucine 5.88 8.30 1.15 1.45
Valine 3.48 5.58 1.23 1.55
Norvaline 3.08 4.80 1.25 1.58
Alanine 2.56 3.15 1.14 1.45
a CSP prepared in current investigation.
b Data from [3] for CSP with another type of immobilization chemistry.
Fig. 2. Separation of enantiomers of amino acids on eremomycin CSP. Column: 250 mm × 4.0 mm. Eluent: methanol–0.1 M NaH2PO4 (20:80, v/v), 0.7 ml/min.
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CSP [7] and with results obtained for alkaloids, amino acids and
peptide antibiotics attached to silica [17–19]. During an attach-
ment the concentration of antibiotics in reaction mixture was
monitored by RP HPLC that allowed determination of reaction
time and confirmation of absence of degradation products of
antibiotic during immobilization.
The chromatographic evaluation of prepared CSP was per-
formed in methanol–water eluents containing different buffers
or additives of acetic acid. Eremomycin CSP demonstrated
a high enantioselectivity in separation of amino acids, espe-
cially aromatic and cyclic iminoacids (Pro, pipecolinic acid)
(Table 1). In accordance to recommendations of ASTec [11],
producer of CSPs with bonded macrocyclic glycopeptide antibi-
otics, teicoplanin, ristocetin A and teicoplanin aglycone CSPs
can be used for the separation of underivatized amino acids, but
not vancomycin CSP. To exclude possible influence of bonding
chemistry under comparison of different CSPs, vancomycin was
attached to epoxy-activated silica under the similar procedure as
for eremomycin CSP. Prepared vancomycin CSP did not show
any significant retention of amino acid enantiomers in studied
mobile phases (k < 0.08–0.2) and noticeable resolution 1.55 was
achieved only for DOPA enantiomers. In fact, it confirms that
the main reason for appearance of enantioselectivity in case of
eremomycin CSP is different structure of bonded chiral selector:
additional carbohydrate residue in eremomycin molecule, miss-














ity for separation of amino acid enantiomers were compared with
literature data for commercially available Chirobiotic R phase
[3,8,11]. Table 2 shows the results on separation of amino acids
enantiomers on two bonded phases under conditions optimal for
Chirobiotic R [3]. The comparison proves that immobilization of
macrocyclic glycopeptide antibiotics onto epoxy-activated silica
under mild conditions can significantly improve the enantiose-
lectivity of CSP with bonded ristocetin A in separation of amino
acid enantiomers.
Thus, eremomycin CSP demonstrated good enantioresolu-
tion of amino acid enantiomers, especially for those having
aromatic substitutes in their molecules. Some examples of sepa-
rations of enantiomers of aromatic amino acids on eremomycin
CSP are shown in Fig. 2. The enantioresolution of this chiral
phase is comparable with commercially available phases with
bonded macrocyclic glycopeptide antibiotics (Fig. 3).
A simplified procedure for attachment of macrocyclic gly-
copeptide antibiotic on epoxy-activated silica under mild con-
ditions from water solutions is proposed. The prepared ere-
momycin CSP demonstrated high enantioselectivity in sep-










[ut not bonding chemistry.
However, the immobilization method can essentially affect
he enantioselectivity of macrocyclic glycopeptide bonded
hase. To check it, one more CSP containing 0.28mol/m2 of
onded ristocetin A was synthesized and data on enantioselectiv-
ig. 3. Comparison of enantioresolution of amino acid enantiomers on dif-
erent CSPs. 1—eremomycin CSP, 2—Chirobiotic TAG, 3—Chirobiotic R
nd 4—Chirobiotic T. Data accumulated from Table 1 and [11]. Mobile
hases for separation of amino acids according to [11]: neutral amino acids;
hirobiotic TAG: methanol/water (30:70, v/v) or methanol/water (60:40,
/v); Chirobiotic R: methanol/water (50:50, v/v) or acetonitrile/water (50:50,
/v); Chirobiotic T: ethanol/water (60:40, v/v); basic amino acids; Chirobi-
tic TAG: methanol/100 mM NaH2PO4 in water (50:50, v/v); Chirobiotic T:
thanol/100 mM NaH2PO4 in water (50:50, v/v).This work was supported by grant N 02.467/11/3004 of Rus-
ian Federal Agency on Science and Innovations.
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